89Zr-TLX250 PET/CT
TLX250CDx-CP-002
Phase 3 small_molecule active
Quick answer
89Zr-TLX250 PET/CT for Clear Cell Renal Cell Carcinoma is a Phase 3 program (small_molecule) at Telix Innovations with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Telix Innovations
- Indication
- Clear Cell Renal Cell Carcinoma
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active